Gujarat Themis Biosyn Ltd
BSE:506879
Intrinsic Value
Gujarat Themis Biosyn Ltd. operates as a pharmaceutical company. [ Read More ]
The intrinsic value of one GUJTHEM stock under the Base Case scenario is 67.77 INR. Compared to the current market price of 396.1 INR, Gujarat Themis Biosyn Ltd is Overvalued by 83%.
Valuation Backtest
Gujarat Themis Biosyn Ltd
Run backtest to discover the historical profit from buying and selling GUJTHEM stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Gujarat Themis Biosyn Ltd
Current Assets | 480.6m |
Cash & Short-Term Investments | 53.2m |
Receivables | 360.4m |
Other Current Assets | 67m |
Non-Current Assets | 1.5B |
Long-Term Investments | 457.6m |
PP&E | 951.5m |
Other Non-Current Assets | 84.1m |
Current Liabilities | 160.6m |
Accounts Payable | 83.8m |
Other Current Liabilities | 76.8m |
Non-Current Liabilities | 33.3m |
Long-Term Debt | 12.1m |
Other Non-Current Liabilities | 21.2m |
Earnings Waterfall
Gujarat Themis Biosyn Ltd
Revenue
|
1.6B
INR
|
Cost of Revenue
|
-609.5m
INR
|
Gross Profit
|
953.2m
INR
|
Operating Expenses
|
-257m
INR
|
Operating Income
|
696.2m
INR
|
Other Expenses
|
-146.5m
INR
|
Net Income
|
549.7m
INR
|
Free Cash Flow Analysis
Gujarat Themis Biosyn Ltd
What is Free Cash Flow?
GUJTHEM Profitability Score
Profitability Due Diligence
Gujarat Themis Biosyn Ltd's profitability score is 77/100. The higher the profitability score, the more profitable the company is.
Score
Gujarat Themis Biosyn Ltd's profitability score is 77/100. The higher the profitability score, the more profitable the company is.
GUJTHEM Solvency Score
Solvency Due Diligence
Gujarat Themis Biosyn Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.
Score
Gujarat Themis Biosyn Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GUJTHEM Price Targets Summary
Gujarat Themis Biosyn Ltd
Shareholder Return
GUJTHEM Price
Gujarat Themis Biosyn Ltd
Average Annual Return | 134.76% |
Standard Deviation of Annual Returns | 133.79% |
Max Drawdown | -21% |
Market Capitalization | 28.8B INR |
Shares Outstanding | 72 643 510 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Gujarat Themis Biosyn Ltd. operates as a pharmaceutical company. The company is headquartered in Mumbai, Maharashtra. The firm operates through manufacturing of bulk drugs segment. The firm's products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin. The firm's research and development division focuses on developing fermentation cultures. The firm's plant is located at Valsad, Gujarat.
Contact
IPO
Employees
Officers
The intrinsic value of one GUJTHEM stock under the Base Case scenario is 67.77 INR.
Compared to the current market price of 396.1 INR, Gujarat Themis Biosyn Ltd is Overvalued by 83%.